Literature DB >> 10644986

Ras/MEK signaling suppresses Myc-dependent apoptosis in cells transformed by c-myc and activated ras.

M Tsuneoka1, E Mekada.   

Abstract

Cooperation of myc and activated ras has been suggested to cause malignant cell transformation but the mechanism is still unknown. Here we isolated a transformed cell line in which activation of c-Myc and Ras are independently controllable, and show that after establishment of the transformed state by c-myc and activated ras, removal of activated Ras initiates apoptosis that is dependent on c-Myc activity. Apoptosis is also initiated by an inhibitor of MEK (MAPK/ERK kinase), a kinase downstream of Ras, and apoptosis is blocked by activated Mek1. These results suggest that one of the conditions required for establishment of the transformed state is a block of apoptosis involving MEK activity. We tested the effect of MEK inhibition on cells transformed by various oncogenes. Suppression of apoptosis by MEK is not critical in general, but in cells transformed by c-myc plus a gene that activates the MAPK cascade it is necessary to avoid cell death. Activated Ras/MEK did not suppress c-myc-dependent apoptosis due to serum-limitation. Overexpression of chicken bcl-xL suppressed apoptosis under serum-limiting conditions, but not apoptosis initiated by Ras/MEK inhibition in cells transformed by myc and activated ras. Altogether, these results suggest the existence of a novel regulatory mechanism for myc-dependent apoptosis in certain transformed cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644986     DOI: 10.1038/sj.onc.1203232

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  A role for K-ras in conferring resistance to the MEK inhibitor, CI-1040.

Authors:  Yuli Wang; Keri Van Becelaere; Ping Jiang; Sally Przybranowski; Charles Omer; Judith Sebolt-Leopold
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

2.  Increased wild-type N-ras activation by neurofibromin down-regulation increases human neuroblastoma stem cell malignancy.

Authors:  Dan Han; Barbara A Spengler; Robert A Ross
Journal:  Genes Cancer       Date:  2011-11

3.  RASSF1A: Not a prototypical Ras effector.

Authors:  Marilyn Gordon; Shairaz Baksh
Journal:  Small GTPases       Date:  2011-05

4.  CpG oligodeoxynucleotide 5mer-induced apoptosis in MOLT-4 leukaemia cells does not require caspase 3 or new protein synthesis.

Authors:  David M Tidd; Caroline M Broughton; Richard E Clark
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

5.  Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis.

Authors:  Catherine M Shachaf; Omar D Perez; Sawsan Youssef; Alice C Fan; Sailaja Elchuri; Matthew J Goldstein; Amy E Shirer; Orr Sharpe; Joy Chen; Dennis J Mitchell; Maria Chang; Garry P Nolan; Lawrence Steinman; Dean W Felsher
Journal:  Blood       Date:  2007-07-10       Impact factor: 22.113

6.  Expression of c-myc is not critical for cell proliferation in established human leukemia lines.

Authors:  D M Tidd; R V Giles; C M Broughton; R E Clark
Journal:  BMC Mol Biol       Date:  2001-11-16       Impact factor: 2.946

7.  MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.

Authors:  Fan Zhang; Siti Mariam Zakaria; Vedrana Högqvist Tabor; Madhurendra Singh; Susanna Tronnersjö; Jacob Goodwin; Galina Selivanova; Jiri Bartek; Alina Castell; Lars-Gunnar Larsson
Journal:  Cell Cycle       Date:  2018-12-17       Impact factor: 4.534

8.  Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.

Authors:  Roderik M Kortlever; Nicole M Sodir; Catherine H Wilson; Deborah L Burkhart; Luca Pellegrinet; Lamorna Brown Swigart; Trevor D Littlewood; Gerard I Evan
Journal:  Cell       Date:  2017-11-30       Impact factor: 41.582

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.